IL129315A0 - Oxadiazoles process for their preparation and their use as medicaments - Google Patents
Oxadiazoles process for their preparation and their use as medicamentsInfo
- Publication number
- IL129315A0 IL129315A0 IL12931597A IL12931597A IL129315A0 IL 129315 A0 IL129315 A0 IL 129315A0 IL 12931597 A IL12931597 A IL 12931597A IL 12931597 A IL12931597 A IL 12931597A IL 129315 A0 IL129315 A0 IL 129315A0
- Authority
- IL
- Israel
- Prior art keywords
- oxadiazoles
- medicaments
- preparation
- oxadiazoles process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19643037A DE19643037A1 (de) | 1996-10-18 | 1996-10-18 | Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
PCT/EP1997/005693 WO1998017652A1 (de) | 1996-10-18 | 1997-10-15 | Oxadiazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
IL129315A0 true IL129315A0 (en) | 2000-02-17 |
Family
ID=7809114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL12931597A IL129315A0 (en) | 1996-10-18 | 1997-10-15 | Oxadiazoles process for their preparation and their use as medicaments |
Country Status (32)
Country | Link |
---|---|
US (1) | US6277872B1 (xx) |
EP (1) | EP0934288B1 (xx) |
JP (1) | JP3333523B2 (xx) |
KR (1) | KR20000049253A (xx) |
CN (1) | CN1086698C (xx) |
AR (1) | AR008496A1 (xx) |
AT (1) | ATE315034T1 (xx) |
AU (1) | AU737552B2 (xx) |
BG (1) | BG103251A (xx) |
BR (1) | BR9714354A (xx) |
CA (1) | CA2268954C (xx) |
CO (1) | CO4920253A1 (xx) |
CZ (1) | CZ138099A3 (xx) |
DE (2) | DE19643037A1 (xx) |
EE (1) | EE9900147A (xx) |
ES (1) | ES2256880T3 (xx) |
HK (1) | HK1020956A1 (xx) |
HR (1) | HRP970553A2 (xx) |
HU (1) | HUP0001652A3 (xx) |
ID (1) | ID18613A (xx) |
IL (1) | IL129315A0 (xx) |
NO (1) | NO312512B1 (xx) |
NZ (1) | NZ335598A (xx) |
PE (1) | PE11199A1 (xx) |
PL (1) | PL332432A1 (xx) |
RU (1) | RU2182905C2 (xx) |
SK (1) | SK49999A3 (xx) |
TR (1) | TR199900848T2 (xx) |
TW (1) | TW413678B (xx) |
WO (1) | WO1998017652A1 (xx) |
YU (1) | YU40997A (xx) |
ZA (1) | ZA979220B (xx) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19816880A1 (de) | 1998-04-17 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue Diphenyl-substituierte 5-Ring-Heterocyclen, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
IT1300056B1 (it) * | 1998-04-17 | 2000-04-05 | Boehringer Ingelheim Italia | Eterocicli con anello a 6 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmaci |
US6107313A (en) * | 1998-10-02 | 2000-08-22 | Combichem, Inc. | Dopamine receptor antagonists |
AU767849B2 (en) | 1999-02-15 | 2003-11-27 | Eisai R&D Management Co., Ltd. | Heterodiazinone derivatives |
ATE257827T1 (de) | 1999-07-21 | 2004-01-15 | Hoffmann La Roche | Triazolderivate |
US6660753B2 (en) | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
EP1582519A3 (en) * | 1999-08-19 | 2005-12-21 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
UA75871C2 (en) * | 1999-08-19 | 2006-06-15 | Nps Pharma Inc | 1,2,4-oxadiazole derivatives and use thereof as antagonists at metabotropic glutamate receptors |
US6579880B2 (en) * | 2000-06-06 | 2003-06-17 | Ortho-Mcneil Pharmaceutical, Inc. | Isoxazoles and oxadiazoles as anti-inflammatory inhibitors of IL-8 |
IL152848A0 (en) | 2000-06-12 | 2003-06-24 | Eisai Co Ltd | 1,2-dihydropyridine derivatives, pharmaceutical compositions containing the same and methods for the production thereof |
NZ524745A (en) * | 2000-09-18 | 2006-01-27 | Eisai Co Ltd | Pyridazinones and triazinones and medicinal use thereof |
RU2319701C2 (ru) * | 2001-02-21 | 2008-03-20 | Астразенека Аб | ГЕТЕРОПОЛИЦИКЛИЧЕСКОЕ СОЕДИНЕНИЕ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ МЕТАБОТРОПНЫХ ГЛЮТАМАТНЫХ РЕЦЕПТОРОВ mGluR ГРУППЫ I |
US7253190B2 (en) * | 2001-10-04 | 2007-08-07 | Merck & Co., Inc. | Heteroaryl substituted tetrazole modulators of metabotrophic glutamate receptor-5 |
MY151199A (en) | 2001-11-02 | 2014-04-30 | Rigel Pharmaceuticals Inc | Substituted diphenyl heterocycles useful for treating hcv infection |
GB0129260D0 (en) | 2001-12-06 | 2002-01-23 | Eisai London Res Lab Ltd | Pharmaceutical compositions and their uses |
AU2003262831A1 (en) | 2002-08-23 | 2004-03-11 | Rigel Pharmaceuticals, Inc. | Pyridyl substituted heterocycles useful for treating or preventing hcv infection |
GB0303503D0 (en) * | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
WO2004099164A1 (en) * | 2003-05-02 | 2004-11-18 | Rigel Pharmaceuticals, Inc. | Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating hcv infection |
WO2004099165A2 (en) | 2003-05-02 | 2004-11-18 | Rigel Pharmaceuticals, Inc. | Heterocyclic compounds and hydro isomers thereof |
US7220745B2 (en) | 2003-05-15 | 2007-05-22 | Rigel Pharmaceuticals | Heterocyclic compounds useful to treat HCV |
WO2005049065A2 (en) | 2003-11-19 | 2005-06-02 | Rigel Pharmaceuticals, Inc. | Synergistic combinations of dihaloacetamide with interferon or ribavirin for treatment hcv infections |
JP4958560B2 (ja) * | 2003-12-24 | 2012-06-20 | プロシディオン・リミテッド | Gpcr受容体作動薬としてのヘテロ環誘導体 |
US7514434B2 (en) | 2004-02-23 | 2009-04-07 | Rigel Pharmaceuticals, Inc. | Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof |
MY148809A (en) | 2004-07-06 | 2013-05-31 | Eisai R&D Man Co Ltd | Crystals of 1,2-dihydropyridine compound and their production process |
WO2006109876A1 (ja) * | 2005-04-08 | 2006-10-19 | Eisai R & D Management Co., Ltd. | 不随意運動治療剤 |
WO2007027230A2 (en) | 2005-05-02 | 2007-03-08 | Rigel Pharmaceuticals, Inc. | Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
GB0510142D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds A1 |
HUP0500920A2 (en) * | 2005-10-05 | 2007-07-30 | Richter Gedeon Nyrt | Oxadiazole derivatives, process for their preparation and their use |
MX2009006304A (es) * | 2006-12-15 | 2009-06-23 | Abbott Lab | Nuevos compuestos de oxadiazol. |
US20110207704A1 (en) * | 2006-12-15 | 2011-08-25 | Abbott Laboratories | Novel Oxadiazole Compounds |
JO2701B1 (en) | 2006-12-21 | 2013-03-03 | جلاكسو جروب ليميتد | Vehicles |
ES2547877T3 (es) * | 2007-10-04 | 2015-10-09 | Merck Serono S.A. | Compuestos diaril-oxadiazol |
US9045442B2 (en) * | 2007-12-21 | 2015-06-02 | University Of Notre Dame Du Lac | Antibacterial compounds and methods of using same |
PL2684873T3 (pl) | 2008-06-09 | 2019-07-31 | Ludwig-Maximilians-Universität München | Leki do hamowania agregacji białek związanych z chorobami związanymi z agregacją białka i/lub chorobami neurodegeneracyjnymi |
US9095596B2 (en) * | 2009-10-15 | 2015-08-04 | Southern Research Institute | Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such |
MX365851B (es) * | 2012-08-24 | 2019-06-17 | Treventis Corp | Compuestos de benzofurazano anti-amiloides y metodos. |
PT3110812T (pt) | 2014-02-27 | 2019-07-10 | Treventis Corp | Compostos antiamiloide contendo benzofurazano |
CN106231905B (zh) | 2014-04-24 | 2019-04-09 | 住友化学株式会社 | 二芳基-唑化合物 |
AU2015319834A1 (en) * | 2014-09-25 | 2017-04-20 | University Of Notre Dame Du Lac | Non-beta lactam antibiotics |
CN107286174B (zh) * | 2016-04-11 | 2020-08-18 | 上海勋和医药科技有限公司 | 取代2,4-(1h,3h)嘧啶二酮作为parp抑制剂及其应用 |
US11168062B2 (en) | 2016-09-12 | 2021-11-09 | University Of Notre Dame Du Lac | Compounds for the treatment of Clostridium difficile infection |
WO2018206778A1 (en) | 2017-05-12 | 2018-11-15 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Phenyl-heterocycle-phenyl derivatives for use in the treatment or prevention of melanoma |
US10676467B2 (en) | 2017-06-30 | 2020-06-09 | Washington University | Compositions for binding sphingosine-1-phosphate receptor 1 (S1P1), imaging of S1P1, and methods of use thereof |
BR112021010953A2 (pt) | 2018-12-14 | 2021-08-24 | Eisai R&D Management Co., Ltd. | Formulações farmacêuticas de base aquosa de compostos de 1,2-di-hidropiridina |
WO2023042887A1 (ja) | 2021-09-15 | 2023-03-23 | 国立大学法人 琉球大学 | 認知機能低下、または過体重もしくは肥満症を処置することに用いるための医薬組成物 |
JPWO2023042888A1 (xx) | 2021-09-15 | 2023-03-23 | ||
EP4173485A1 (en) | 2021-10-27 | 2023-05-03 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Protein aggregation inhibiting compounds for plant disease control |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4003909A (en) * | 1974-07-22 | 1977-01-18 | E. R. Squibb & Sons, Inc. | [(1,2,4-Oxadiazol-3-yl)phenyl]carbamic or thiocarbamic acid esters |
JPS52272A (en) * | 1975-10-17 | 1977-01-05 | Takeda Chem Ind Ltd | Process for preparing 1,2,4-oxadiazole derivatives |
DE2801509A1 (de) * | 1978-01-12 | 1979-07-19 | Schering Ag | 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel |
JPS58150576A (ja) * | 1982-03-03 | 1983-09-07 | Sumitomo Chem Co Ltd | 新規な1,2,4−オキサジアゾ−ル誘導体 |
EP0276432A3 (de) * | 1986-12-12 | 1988-10-26 | Ciba-Geigy Ag | Schädlingsbekämpfungsmittel |
DE3905242A1 (de) * | 1989-02-21 | 1990-08-23 | Basf Ag | Verfahren zur herstellung von phenyloxdiazolylanilinen |
JPH02250873A (ja) * | 1989-03-24 | 1990-10-08 | Mitsubishi Petrochem Co Ltd | 1,2,4―オキサジアゾール誘導体及びそれを有効成分とする除草剤 |
NZ234760A (en) * | 1989-08-18 | 1991-09-25 | Sterling Drug Inc | Antiviral oxazole compounds and compositions |
DK443489D0 (da) * | 1989-09-08 | 1989-09-08 | Ferrosan As | Substituerede urinstofforbindelser, deres fremstilling og anvendelse |
JPH04295470A (ja) * | 1991-03-22 | 1992-10-20 | Wakamoto Pharmaceut Co Ltd | モノアミンオキシダーゼ−b酵素阻害活性を有する1,2,4−オキサジアゾール誘導体及びその製造法 |
WO1993002677A1 (en) * | 1991-08-03 | 1993-02-18 | Smithkline Beecham Plc | 5-ht4 receptor antagonists |
DE4401108A1 (de) * | 1994-01-17 | 1995-07-20 | Bayer Ag | 1,2,4-Oxadiazol-Derivate |
DE4401107A1 (de) * | 1994-01-17 | 1995-07-20 | Bayer Ag | 3-Aryl-alkenyl-1,2,4-oxadiazol-Derivate |
DE19528189A1 (de) * | 1995-08-01 | 1997-02-06 | Basf Ag | Benzolderivate mit einem heterocyclischen Rest |
-
1996
- 1996-10-18 DE DE19643037A patent/DE19643037A1/de not_active Withdrawn
-
1997
- 1997-10-15 KR KR1019990703360A patent/KR20000049253A/ko not_active Application Discontinuation
- 1997-10-15 HU HU0001652A patent/HUP0001652A3/hu unknown
- 1997-10-15 CZ CZ991380A patent/CZ138099A3/cs unknown
- 1997-10-15 CN CN97198866A patent/CN1086698C/zh not_active Expired - Fee Related
- 1997-10-15 EP EP97911227A patent/EP0934288B1/de not_active Expired - Lifetime
- 1997-10-15 WO PCT/EP1997/005693 patent/WO1998017652A1/de active IP Right Grant
- 1997-10-15 ZA ZA9709220A patent/ZA979220B/xx unknown
- 1997-10-15 AT AT97911227T patent/ATE315034T1/de active
- 1997-10-15 TR TR1999/00848T patent/TR199900848T2/xx unknown
- 1997-10-15 DE DE59712543T patent/DE59712543D1/de not_active Expired - Lifetime
- 1997-10-15 EE EEP199900147A patent/EE9900147A/xx unknown
- 1997-10-15 BR BR9714354-5A patent/BR9714354A/pt not_active IP Right Cessation
- 1997-10-15 RU RU99111781/04A patent/RU2182905C2/ru not_active IP Right Cessation
- 1997-10-15 PE PE1997000910A patent/PE11199A1/es not_active Application Discontinuation
- 1997-10-15 SK SK499-99A patent/SK49999A3/sk unknown
- 1997-10-15 US US09/284,382 patent/US6277872B1/en not_active Expired - Lifetime
- 1997-10-15 PL PL97332432A patent/PL332432A1/xx unknown
- 1997-10-15 JP JP50563998A patent/JP3333523B2/ja not_active Expired - Lifetime
- 1997-10-15 CA CA002268954A patent/CA2268954C/en not_active Expired - Fee Related
- 1997-10-15 IL IL12931597A patent/IL129315A0/xx unknown
- 1997-10-15 AU AU48676/97A patent/AU737552B2/en not_active Ceased
- 1997-10-15 NZ NZ335598A patent/NZ335598A/en unknown
- 1997-10-15 ES ES97911227T patent/ES2256880T3/es not_active Expired - Lifetime
- 1997-10-16 YU YU40997A patent/YU40997A/sh unknown
- 1997-10-16 HR HR19643037.2A patent/HRP970553A2/hr not_active Application Discontinuation
- 1997-10-16 ID IDP973449A patent/ID18613A/id unknown
- 1997-10-17 AR ARP970104812A patent/AR008496A1/es not_active Application Discontinuation
- 1997-10-17 CO CO97061157A patent/CO4920253A1/es unknown
- 1997-10-18 TW TW086115386A patent/TW413678B/zh not_active IP Right Cessation
-
1999
- 1999-03-15 BG BG103251A patent/BG103251A/xx active Pending
- 1999-04-16 NO NO19991815A patent/NO312512B1/no not_active IP Right Cessation
- 1999-12-29 HK HK99106174A patent/HK1020956A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL129315A0 (en) | Oxadiazoles process for their preparation and their use as medicaments | |
AP9901556A0 (en) | Sulpponamide derivatives process for their preparation and their use as medicaments | |
ZA953501B (en) | Erythromycin derivatives their preparation process and their use as medicaments | |
ZA952059B (en) | Erythromycin derivatives their preparation process and their use as medicaments | |
AP9901444A0 (en) | Erythrommycins and process for their preparation | |
EP0960934A4 (en) | PHYTASE AND METHOD FOR THE PRODUCTION THEREOF | |
IL114795A0 (en) | N-benzylindole- and benmzopyrazole derivatives their preparation and use | |
HUP0000426A3 (en) | Novel benzonaphthyridines, pharmaceutical compositions and use thereof and process for their preparation | |
HU9501086D0 (en) | Organoaluminoxy product, preparation and use | |
HK1040980A1 (zh) | 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途 | |
HUP9901434A3 (en) | Substituted benzylamines and their use for the preparation of medicaments for treating depression | |
CZ63895A3 (en) | 5-vinyl-quinolone-carboxylic, 5-vinyl-naphthyridon-carboxylic, +5-ethinyl-quinolone-carboxylic and 5-ethinyl-naphthyridon-carboxylic acids, process of their preparation, medicaments in which said compounds are comprised and their use | |
ZA988285B (en) | 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-oles process for their preparation and their use for medicaments | |
IL120924A0 (en) | Substituted 2-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them | |
EP0890599A4 (en) | POLYORGANOSILOXANES AND METHOD FOR THE PRODUCTION THEREOF | |
GB9408053D0 (en) | Pharmaceutical preparation | |
HUP9600665A3 (en) | Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation | |
IL120988A0 (en) | Ortho-substituded benzoylguenidines process for their preparation their use as a medicament comprising them | |
HU9500466D0 (en) | Fungicidal 2-imidazoline-5-one derivatives and process for their preparation | |
IL121407A0 (en) | Substituted indanylidineacetylguanidines process for their preparation their use as medicaments or in diagnosis and medicaments containing them | |
GR3035834T3 (en) | Benzoxazindione derivatives, process for their preparation and their use | |
IL120925A0 (en) | Substituted 1-naphthoylguanidines process for their preparation their use as a medicament or diagnostic and medicaments containing them | |
HU9502244D0 (en) | 3-substituted 5-quinolinecarboxylicacid-derivative and process for its preparation | |
IL126827A0 (en) | Substituted phenyluracils a process for their preparation and the use thereof | |
AU3982695A (en) | Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments |